Compounds and their uses for alleviating menopause-associated symptoms
AssigneeEstetra Sprl
InventorsMelanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
Life of this patent
Estimating the term…
Abstract
The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
Claims7
A method of alleviating menopause-associated symptoms, comprising of orally administering once daily a composition formulated as a daily oral dosage unit comprising from about 15 mg to about 20 mg estetrol monohydrate.
Dependencies are inferred from the claim text.